These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 16318718)
1. Cervical human papillomavirus screening among older women. Grainge MJ; Seth R; Guo L; Neal KR; Coupland C; Vryenhoef P; Johnson J; Jenkins D Emerg Infect Dis; 2005 Nov; 11(11):1680-5. PubMed ID: 16318718 [TBL] [Abstract][Full Text] [Related]
2. HPV presence precedes abnormal cytology in women developing cervical cancer and signals false negative smears. Zielinski GD; Snijders PJ; Rozendaal L; Voorhorst FJ; van der Linden HC; Runsink AP; de Schipper FA; Meijer CJ Br J Cancer; 2001 Aug; 85(3):398-404. PubMed ID: 11487272 [TBL] [Abstract][Full Text] [Related]
3. Age-specific detection of high risk HPV DNA in cytologically normal, computer-imaged ThinPrep Pap samples. Cibas ES; Hong X; Crum CP; Feldman S Gynecol Oncol; 2007 Mar; 104(3):702-6. PubMed ID: 17150245 [TBL] [Abstract][Full Text] [Related]
4. Human papillomavirus prevalence at the USA-Mexico border among women 40 years of age and older. Giuliano AR; Papenfuss MR; Denman CA; de Zapien JG; Abrahamsen M; Hunter JB Int J STD AIDS; 2005 Mar; 16(3):247-51. PubMed ID: 15829027 [TBL] [Abstract][Full Text] [Related]
5. Cervical cancer screening with both human papillomavirus and Papanicolaou testing vs Papanicolaou testing alone: what screening intervals are physicians recommending? Saraiya M; Berkowitz Z; Yabroff KR; Wideroff L; Kobrin S; Benard V Arch Intern Med; 2010 Jun; 170(11):977-85. PubMed ID: 20548011 [TBL] [Abstract][Full Text] [Related]
6. Rightsizing cervical cancer screening: comment on "Cervical cancer screening with both human papillomavirus and Papanicolaou testing vs Papanicolaou testing alone". Sawaya GF Arch Intern Med; 2010 Jun; 170(11):985-6. PubMed ID: 20548012 [No Abstract] [Full Text] [Related]
7. Low prevalence of high-risk HPV in older women not attending organized cytological screening: a pilot study. Wikström I; Stenvall H; Wilander E Acta Derm Venereol; 2007; 87(6):554-5. PubMed ID: 17989903 [No Abstract] [Full Text] [Related]
8. Prevalence, evolution, and features of infection with human papillomavirus: a 15-year longitudinal study of routine screening of a women population in the north of Spain. de Oña M; Alvarez-Argüelles ME; Torrents M; Villa L; Rodriguez-Feijoo A; Palacio A; Boga JA; Tamargo A; Melón S J Med Virol; 2010 Apr; 82(4):597-604. PubMed ID: 20166173 [TBL] [Abstract][Full Text] [Related]
9. Prevalence and genotype distribution of multiple human papillomavirus infection in the uterine cervix: a 7.5-year longitudinal study in a routine cytology-based screening population in West Germany. Kovács K; Varnai AD; Bollmann M; Bankfalvi A; Szendy M; Speich N; Schmitt C; Pajor L; Bollmann R J Med Virol; 2008 Oct; 80(10):1814-23. PubMed ID: 18712836 [TBL] [Abstract][Full Text] [Related]
11. Detection of 14 human papillomavirus genotypes in cervical samples in women from a central-southern area of Italy showing different Pap test results. Zappacosta B; Romano L; Guerriero M; Graziano M; Vitrani A; De Ninno M; Carbone A New Microbiol; 2009 Oct; 32(4):351-8. PubMed ID: 20128441 [TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus in cell samples from Stockholm Gynecologic Health Screening. Hagmar B; Kalantari M; Skyldberg B; Moberger B; Johansson B; Walaas L; Wärleby B Acta Cytol; 1995; 39(4):741-5. PubMed ID: 7631548 [TBL] [Abstract][Full Text] [Related]
13. Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer. Wallin KL; Wiklund F; Angström T; Bergman F; Stendahl U; Wadell G; Hallmans G; Dillner J N Engl J Med; 1999 Nov; 341(22):1633-8. PubMed ID: 10572150 [TBL] [Abstract][Full Text] [Related]
14. [Estimation of HPV infection presence in cytological smears in a group of asymptomatic women]. Łukaszuk K; Liss J; Zalewski J; Roter M; Brzóska B; Debniak J Wiad Lek; 2001; 54(9-10):508-15. PubMed ID: 11816294 [TBL] [Abstract][Full Text] [Related]
15. Prevalence and risk factors for human papillomavirus DNA in cervical cytology. Kasap B; Yetimalar H; Keklik A; Yildiz A; Cukurova K; Soylu F Eur J Obstet Gynecol Reprod Biol; 2011 Nov; 159(1):168-71. PubMed ID: 21764503 [TBL] [Abstract][Full Text] [Related]
16. Prevalence of high-risk human papillomavirus type 16/18 infection among women with normal cytology: risk factor analysis and implications for screening and prophylaxis. Gupta S; Sodhani P; Sharma A; Sharma JK; Halder K; Charchra KL; Sardana S; Singh V; Sehgal A; Das BC Cytopathology; 2009 Aug; 20(4):249-55. PubMed ID: 19018810 [TBL] [Abstract][Full Text] [Related]
17. Human papillomavirus infection (HPV) & screening strategies for cervical cancer. Sehgal A; Singh V Indian J Med Res; 2009 Sep; 130(3):234-40. PubMed ID: 19901432 [TBL] [Abstract][Full Text] [Related]
18. Can cervical cancer screening be stopped at 50? The prevalence of HPV in elderly women. Baay MF; Smits E; Tjalma WA; Lardon F; Weyler J; Van Royen P; Van Marck EA; Vermorken JB Int J Cancer; 2004 Jan; 108(2):258-61. PubMed ID: 14639612 [TBL] [Abstract][Full Text] [Related]
19. Screening for genital human papillomavirus: results from an international validation study on human papillomavirus sampling techniques. de Sanjosé S; Bosch XF; Muñoz N; Chichareon S; Ngelangel C; Balagueró L; Jacobs MV; Meijer CJ; Walboomers JM Diagn Mol Pathol; 1999 Mar; 8(1):26-31. PubMed ID: 10408790 [TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus detection from human immunodeficiency virus-infected Colombian women's paired urine and cervical samples. Munoz M; Camargo M; Soto-De Leon SC; Sanchez R; Parra D; Pineda AC; Sussmann O; Perez-Prados A; Patarroyo ME; Patarroyo MA PLoS One; 2013; 8(2):e56509. PubMed ID: 23418581 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]